SCHEMBL3580141

SCHEMBL3580141

c1nnc(N2CC23CCC3)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL689799 0.64 NOTUM (0.39) —
SCHEMBL1557004 0.62 CHRNB2 (0.48) —
SCHEMBL3475475 0.55 KDM4E (0.36) —
SCHEMBL12906161 0.51 NOTUM (0.59) —
SCHEMBL4743084 0.49 NOTUM (0.50) —
SCHEMBL17694561 0.45 NOTUM (0.78) —
SCHEMBL21795694 0.45 NOTUM (0.75) —
SCHEMBL24221051 0.44 — —
SCHEMBL22750752 0.44 — —
SCHEMBL22557718 0.44 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7754708-B2 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof TARGACEPT, INC. (US) 2010-07-13 — — US disclosed
US-20080242689-A1 Analgesics, central nervous system disorders, obesity, side effect reduction BHATTI BALWINDER 2008-10-02 — — US disclosed
Send feedback